Chronic kidney disease in adults--UK guidelines for identification, management and referral.
暂无分享,去创建一个
[1] P. Raggi,et al. Determinants of progressive vascular calcification in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[3] G. Remuzzi,et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). , 1998, Kidney international.
[4] P. Krijnen,et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] I. Piña,et al. Practical recommendations for the use of ACE inhibitors, beta‐blockers and spironolactone in heart failure: putting guidelines into practice , 2001, European journal of heart failure.
[6] N. Levinsky. Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.
[7] A. Collins,et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? , 2005, Kidney international.
[8] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[9] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.
[10] T. Hannedouche,et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] Merlin C. Thomas,et al. Unrecognized anemia in patients with diabetes: a cross-sectional survey. , 2003, Diabetes care.
[12] C. Price,et al. Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. , 1999, Clinical nephrology.
[13] R. Selgas,et al. Significado pronóstico de la diálisis programada en pacientes que inician tratamiento sustitutivo renal: Un estudio multicéntrico español , 2002 .
[14] B. Pereira,et al. Optimization of pre-ESRD care: the key to improved dialysis outcomes. , 2000, Kidney international.
[15] P. Aliabadi,et al. Intact parathyroid hormone levels in renal insufficiency , 1995, Calcified Tissue International.
[16] Edward H. Wagner,et al. A Survey of Leading Chronic Disease Management Programs: Are They Consistent with the Literature? , 2002, Managed care quarterly.
[17] T. Weinstein,et al. The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.
[18] J. Buring,et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. , 2003, Journal of the American Society of Nephrology : JASN.
[19] G. Eknoyan,et al. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. , 2002, Journal of the American Society of Nephrology : JASN.
[20] J. Stoves,et al. Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis , 2001, Postgraduate medical journal.
[21] A. Cass,et al. Late referral to a nephrologist reduces access to renal transplantation. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] J. Miller,et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.
[23] A. Stack. Determinants of modality selection among incident US dialysis patients: results from a national study. , 2002, Journal of the American Society of Nephrology : JASN.
[24] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[25] K. Farrington,et al. Renal biopsy in patients with unexplained renal impairment and normal kidney size. , 1989, The Quarterly journal of medicine.
[26] H. Parving,et al. EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.
[27] A. Charlesworth,et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.
[28] John Simes,et al. Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease , 2004, Circulation.
[29] J. Aparicio,et al. Late renal failure due to prostatic outflow obstruction: a preventable disease. , 1989, BMJ.
[30] A. Kausz,et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. , 1999, Journal of the American Society of Nephrology : JASN.
[31] R. Chesney,et al. Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement , 1994, Annals of Internal Medicine.
[32] D. Fliser,et al. Renal functional reserve in healthy elderly subjects. , 1993, Journal of the American Society of Nephrology : JASN.
[33] D. Silverberg. Outcomes of anaemia management in renal insufficiency and cardiac disease. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] C. O. Alebiosu. An update on 'progression promoters' in renal diseases. , 2003, Journal of the National Medical Association.
[35] H. Parving,et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. , 2002, Kidney international.
[36] R. Wolfe,et al. Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.
[37] B. Giraudeau,et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. , 2000, Kidney international.
[38] Avid,et al. THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN , 2000 .
[39] P. Kalra,et al. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[40] A. Dowell,et al. Dipstick haematuria and bladder cancer in men over 60: results of a community study. , 1989, BMJ.
[41] J. Dippell,et al. Non-neurogenic bladder and chronic renal insufficiency in childhood , 1995, Pediatric Nephrology.
[42] T V Perneger,et al. Projections of hypertension-related renal disease in middle-aged residents of the United States. , 1993, JAMA.
[43] G. Fonarow,et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.
[44] Hans L Hillege,et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.
[45] L. Baker,et al. Temporary vascular access for first dialysis is common, undesirable and usually avoidable. , 1999, Clinical nephrology.
[46] Amit X Garg,et al. Classifying kidney problems: can we avoid framing risks as diseases? , 2004, BMJ : British Medical Journal.
[47] C. Gullion,et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.
[48] G. Burke,et al. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. , 2000, Kidney international.
[49] F. W. Wright,et al. Who gets renal bone disease before beginning dialysis? , 1985, British medical journal.
[50] G. Bakris,et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. , 2004, Kidney international.
[51] Jerry Avorn,et al. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. , 2003, Kidney international.
[52] B. Astor,et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.
[53] J. Schmidt,et al. Complications, results and problems of ileal conduit diversions. , 1973, The Journal of urology.
[54] L. Poston,et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.
[55] Zhongxin Zhang,et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.
[56] K. Siamopoulos,et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. , 2004, Kidney international.
[57] R. Pollastro,et al. Glomerular filtration rate in severely overweight normotensive humans. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] M. Roland,et al. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure , 1999, BMJ.
[59] T. Greene,et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.
[60] W. van Biesen,et al. The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[61] K. Farrington,et al. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity , 1999, BMJ.
[62] A. Crosswaite,et al. General practitioners with special clinical interests. , 2002, Clinical medicine.
[63] R. J. Valentine,et al. The coronary risk of unsuspected renal artery stenosis. , 1993, Journal of vascular surgery.
[64] J. Avorn,et al. Nephrologist care and mortality in patients with chronic renal insufficiency. , 2002, Archives of internal medicine.
[65] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[66] Marsha A Raebel,et al. Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease , 2004, The Annals of pharmacotherapy.
[67] J. Teichman,et al. Long-term renal fate and prognosis after staghorn calculus management. , 1995, The Journal of urology.
[68] J. Avorn,et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. , 2003, Journal of the American Society of Nephrology : JASN.
[69] V. Manninen,et al. Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.
[70] R. Simó,et al. Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective study. , 2004, Diabetes care.
[71] S. Zimmerman,et al. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. , 1980, Clinical nephrology.
[72] L. Hutchison,et al. BONE METABOLISM AND DISEASE IN CHRONIC KIDNEY DISEASE , 2007 .
[73] C. Mogensen,et al. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature , 1996, Diabetologia.
[74] A. Blumsohn,et al. Parathyroid hormone: what are we measuring and does it matter? , 2002, Annals of clinical biochemistry.
[75] G. Feder,et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003, Quality & safety in health care.
[76] F. Ierino,et al. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury , 2003, Annals of clinical biochemistry.
[77] E. Kaarsalo,et al. Prevalence and incidence of moderate and severe chronic renal failure in south-western Finland, 1973-76. , 2009, Acta medica Scandinavica.
[78] G. Prescott,et al. Can we improve early mortality in patients receiving renal replacement therapy? , 2000, Kidney international.
[79] Cohen-Solal Alain,et al. Practical recommendations for the use of ACE inhibitors, beta‐blockers and spironolactone in heart failure: putting guidelines into practice , 2001 .
[80] V. Vaccarino,et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. , 2003, Kidney international.
[81] D. O'donoghue,et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[82] O. Wiklund,et al. Cholesterol: a renal risk factor in diabetic nephropathy? , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[83] W. Mali,et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. , 2001, Journal of the American Society of Nephrology : JASN.
[84] G. MacGregor,et al. Renal artery stenosis masquerading as congestive heart failure , 1993, The Lancet.
[85] A. Levey,et al. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. , 1997, Annals of internal medicine.
[86] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .
[87] E. Will. Targets and targeting. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[88] J. C. Smith,et al. Prevalence and outcome of renal impairment at prostatectomy. , 1993, British journal of urology.
[89] V. D’Agati,et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. , 2000, Journal of the American Society of Nephrology : JASN.
[90] R. Prince,et al. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. , 1992, Nephron.
[91] C. Price,et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.
[92] I. Ala-Houhala,et al. Long-term renal dysfunction in patients with acute urinary retention. , 2001, Scandinavian journal of urology and nephrology.
[93] P. Poole‐Wilson,et al. Haemoglobin concentration and prognosis in new cases of heart failure , 2003, The Lancet.
[94] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[95] U. Jonas,et al. Long-term followup of children with colon conduit urinary diversion and ureterosigmoidostomy. , 1977, The Journal of urology.
[96] A. Garg,et al. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. , 2001, Kidney international.
[97] A. Jaffe,et al. Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.
[98] D. Zeeuw,et al. Sodium intake affects urinary albumin excretion especially in overweight subjects , 2004, Journal of internal medicine.
[99] B. Kasiske,et al. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1997, Kidney international. Supplement.
[100] C. Fraser,et al. Biological Variation of Serum and Urine Creatinine and Creatinine Clearance: Ramifications for Interpretation of Results and Patient Care , 1988, Annals of clinical biochemistry.
[101] J. Buring,et al. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. , 2005, Archives of internal medicine.
[102] W. Keane,et al. Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. , 2003, Kidney international. Supplement.
[103] M. Bédard,et al. Assessment of Adherence to Renal Dosing Guidelines in Long‐Term Care Facilities , 2000, Journal of the American Geriatrics Society.
[104] A. Donker,et al. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial , 2002, European Journal of Clinical Nutrition.
[105] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[106] J. Singer,et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[107] K. Khaw,et al. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. , 1992, BMJ.
[108] D. Young,et al. Follow-Up of Spina Bifida Children with and without Upper Renal Tract Changes at Birth , 1991, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[109] C. Ahn,et al. Renal biopsy in elderly patients: clinicopathological correlation in 117 Korean patients. , 2001, Clinical nephrology.
[110] N. Powe,et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.
[111] D. de Zeeuw,et al. Smoking Is Related to Albuminuria and Abnormal Renal Function in Nondiabetic Persons , 2000, Annals of Internal Medicine.
[112] C. Marcantoni,et al. Lessons from large interventional trials on antihypertensive therapy in chronic renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[113] S. Ganesh,et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. , 2001, Journal of the American Society of Nephrology : JASN.
[114] G. Eknoyan,et al. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[115] I. Holme,et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.
[116] M. Landray,et al. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[117] Akihiko Hirata,et al. [Cystatin C]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[118] Cy Hsu. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials , 2001, Journal of Human Hypertension.
[119] G. Remuzzi,et al. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes , 1998, BMJ.
[120] P. Dieppe,et al. Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs , 2004, BMJ : British Medical Journal.
[121] P. Roderick,et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[122] Michèle Kessler,et al. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[123] D. de Zeeuw,et al. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. , 1989, Kidney international.
[124] E. Bergstralh,et al. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. , 1994, The New England journal of medicine.
[125] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[126] C. Schmid,et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. , 2001, Annals of internal medicine.
[127] C. Díaz-Corte,et al. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[128] E. Morales,et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[129] M. Pauly,et al. Predictors of type of vascular access in hemodialysis patients. , 1996, JAMA.
[130] David Voss,et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. , 2004, Journal of the American Society of Nephrology : JASN.
[131] R A Kronmal,et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. , 1998, JAMA.
[132] A. Bellucci,et al. Survival estimates for 683 patients starting dialysis from 1970 through 1989: identification of risk factors for survival. , 1994, Clinical nephrology.
[133] D. Abrahamson,et al. Derivation and differentiation of glomerular endothelial cells. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[134] R. Dalton,et al. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients , 2005, Annals of clinical biochemistry.
[135] G. Gambaro,et al. Risk for renal failure in nephrolithiasis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[136] J. Feehally,et al. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible , 1992, Journal of internal medicine.
[137] T. Bajwa,et al. High incidence of renal artery stenosis in patients with coronary artery disease. , 1994, Catheterization and cardiovascular diagnosis.
[138] S. H. Norris,et al. Paraneoplastic glomerulopathies. , 1993, Seminars in nephrology.
[139] F. Cluzeau,et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003 .
[140] A. Hungin,et al. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study , 2003, BMJ : British Medical Journal.
[141] C. McCulloch,et al. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. , 2002, Kidney international.
[142] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[143] Petros Nihoyannopoulos,et al. Joint British recommendations on prevention of coronary heart disease in clinical practice , 1998, Heart.
[144] N. Ismail,et al. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[145] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[146] C. Jackson,et al. MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.
[147] H. Cardinal,et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. , 2000, Clinical chemistry.
[148] A. Mimran,et al. Dietary sodium and target organ damage in essential hypertension. , 2002, American journal of hypertension.
[149] Moorthy Av,et al. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. , 1980 .
[150] D. de Zeeuw,et al. A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. , 1997, Kidney international.
[151] Harlan M Krumholz,et al. The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.
[152] Tom Chan,et al. Identifying patients with chronic kidney disease from general practice computer records. , 2005, Family practice.
[153] A. Nissenson,et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. , 2001, Journal of the American Society of Nephrology : JASN.
[154] A. Garg,et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.
[155] R. Minutolo,et al. Salt Intake and Renal Outcome in Patients with Progressive Renal Disease , 1998, Mineral and Electrolyte Metabolism.
[156] H. Hillege,et al. Low Levels of Urinary Albumin Excretion Are Associated with Cardiovascular Risk Factors in the General Population , 2000, Clinical chemistry and laboratory medicine.
[157] W. Peh. Renal osteodystrophy. , 2002, American journal of orthopedics.
[158] P. Roderick,et al. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions. , 1998, QJM : monthly journal of the Association of Physicians.
[159] Ruth Davies,et al. Simulation model of renal replacement therapy: predicting future demand in England. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[160] B. Brenner,et al. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.
[161] P. Whelton,et al. Risk of end-stage renal disease associated with alcohol consumption. , 1999, American journal of epidemiology.
[162] B. Leese,et al. The role of UK general practitioners with special clinical interests: implications for policy and service delivery. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.
[163] R. Woolfson,et al. Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention , 2001, Postgraduate medical journal.
[164] S. Wannamethee,et al. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. , 1997, Stroke.
[165] B. Davis,et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. , 2004, Archives of internal medicine.
[166] J. Richie. Intestinal loop urinary diversion in children. , 1974, The Journal of urology.
[167] J. Stanley,et al. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. , 1992, Journal of vascular surgery.
[168] W. Mali,et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. , 1998, Kidney international.
[169] V. Dzau. Renal and circulatory mechanisms in congestive heart failure. , 1987, Kidney international.
[170] P. Roderick,et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[171] Hans L. Hillege,et al. Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria , 2004, Circulation.
[172] A. Kshirsagar,et al. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[173] P. S. Williams,et al. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. , 1988, The Quarterly journal of medicine.
[174] C. Lazure,et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. , 1998, Clinical chemistry.
[175] P. Ellis,et al. Late referral of end-stage renal failure. , 1998, QJM : monthly journal of the Association of Physicians.
[176] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[177] L. Ramsay,et al. IS "IMPROVEMENT" REAL WITH PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN THE MANAGEMENT OF RENOVASCULAR HYPERTENSION? , 1987, The Lancet.
[178] B. Churchill,et al. Nonrefluxing colonic conduits: a long-term life-table analysis. , 1989, The Journal of urology.
[179] Brian T. Austin,et al. Improving chronic illness care: translating evidence into action. , 2001, Health affairs.
[180] F. Pugliese,et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[181] H. Parving,et al. Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[182] L. Smith,et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. , 1992, Journal of the American Society of Nephrology : JASN.
[183] Jiang He,et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.
[184] J. Bernheim,et al. Is renal biopsy justified for the diagnosis and management of the nephrotic syndrome in the elderly? , 1993, Gerontology.
[185] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[186] A. Jardine,et al. Why do we need a statin trial in hemodialysis patients? , 2003, Kidney international. Supplement.
[187] J. Craig,et al. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. , 2003, The Cochrane database of systematic reviews.
[188] R. Barnard,et al. High pressure chronic retention. , 1983, British medical journal.
[189] C. Baigent,et al. Study of Heart and Renal Protection (SHARP). , 2003, Kidney international. Supplement.
[190] J. Diamond. Flash pulmonary edema and the diagnostic suspicion of occult renal artery stenosis. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[191] C. Jurkovitz,et al. Screening for chronic kidney disease: unresolved issues. , 2003, Journal of the American Society of Nephrology : JASN.
[192] J. Coresh,et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.
[193] L. Huiart,et al. Timing of nephrology referral: influence on mortality and morbidity. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[194] A. Rule,et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. , 2005, Kidney international.
[195] Tom Greene,et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.
[196] G. Beck,et al. The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.
[197] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[198] R. Feneley,et al. Identification of the poor risk patient with "prostatism" and detrusor failure. , 1986, British journal of urology.
[199] J. Laragh,et al. RECURRENT PULMONARY OEDEMA IN HYPERTENSION DUE TO BILATERAL RENAL ARTERY STENOSIS: TREATMENT BY ANGIOPLASTY OR SURGICAL REVASCULARISATION , 1988, The Lancet.
[200] P. Cannon. The kidney in heart failure. , 1977, The New England journal of medicine.
[201] E. Ritz,et al. Adverse effect of smoking on renal function in the general population: are men at higher risk? , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[202] D. Brewster,et al. Angiography in the management of aneurysms of the abdominal aorta. Its value and safety. , 1975, The New England journal of medicine.
[203] A. Garg,et al. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). , 2002, Journal of the American Society of Nephrology : JASN.
[204] N. Polissar,et al. Prospective study of atherosclerotic disease progression in the renal artery. , 1998, Circulation.
[205] Paul W Armstrong,et al. Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.
[206] R. Lindeman. Is the decline in renal function with normal aging inevitable? , 1998, Geriatric nephrology and urology.
[207] K. Lynn,et al. Renal biopsy: an appraisal of its role in clinical nephrology. , 1981, The New Zealand medical journal.
[208] W. Rand,et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.
[209] M. Haneda,et al. Progression of diabetic nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[210] D. B. Paone,et al. The effect of biopsy on therapy in renal disease. , 1981, Archives of internal medicine.
[211] Deeb N Salem,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.
[212] T. Larson,et al. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. , 2001, Journal of the American Society of Nephrology : JASN.
[213] J. Walls,et al. SELECTION-ADJUSTED COMPARISON OF LIFE-EXPECTANCY OF PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, HAEMODIALYSIS, AND RENAL TRANSPLANTATION , 1987, The Lancet.
[214] E. Ritz,et al. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[215] M. Cooper,et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study , 2000, BMJ : British Medical Journal.
[216] P. Roderick,et al. Predicting the future demand for renal replacement therapy in England using simulation modelling. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[217] D. Schwartz,et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[218] S. Romundstad,et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[219] Geoff Venning,et al. Recent developments in vitamin D deficiency and muscle weakness among elderly people , 2005, BMJ : British Medical Journal.
[220] I. Khan,et al. Identifying the high-risk dialysis patient: what are the benefits? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[221] P. Krijnen,et al. Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens , 2001, Journal of Human Hypertension.
[222] Bess Dawson-Hughes,et al. Effect of Vitamin D on falls: a meta-analysis. , 2004, JAMA.
[223] J Main,et al. How Important Is Atheromatous Renal Artery Stenosis as a Cause of End‐Stage Renal Disease? , 2001, Seminars in dialysis.
[224] Josef Coresh,et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. , 2003, Journal of the American Society of Nephrology : JASN.
[225] M. Mihatsch,et al. Morphologic findings in "zero-hour" biopsies of renal transplants. , 1991, Clinical nephrology.
[226] R. Foley,et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. , 2002, Journal of the American Society of Nephrology : JASN.
[227] P. Kalra,et al. Individual kidney function before and after renal angioplasty , 1998, The Lancet.
[228] J. Kanis,et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure , 1995, BMJ.
[229] F. Sacks,et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. , 2003, Journal of the American Society of Nephrology : JASN.
[230] D. Cohen,et al. Renal failure in the recipients of nonrenal solid organ transplants. , 1999, Journal of the American Society of Nephrology : JASN.
[231] E H Wagner,et al. Quality improvement in chronic illness care: a collaborative approach. , 2001, The Joint Commission journal on quality improvement.
[232] Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .
[234] Corrigan,et al. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease , 2000, Alimentary pharmacology & therapeutics.
[235] T. Larson,et al. Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.
[236] G. Navis,et al. Renoprotective therapy: titration against urinary protein excretion , 1999, The Lancet.
[237] W. Kannel,et al. The prognostic significance of proteinuria: the Framingham study. , 1984, American heart journal.
[238] M. Jaff,et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four‐year follow‐up of 1,058 successful patients , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[239] M. World,et al. Mesalazine-associated interstitial nephritis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[240] J. Lanke,et al. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed , 2001, European Psychiatry.
[241] C. Alling,et al. Renal function and biopsy findings in patients on long-term lithium treatment. , 1981, Kidney international.
[242] F. Kronenberg,et al. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. , 2002, Journal of the American Society of Nephrology : JASN.
[243] P. Jungers,et al. Late referral to maintenance dialysis: detrimental consequences. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[244] P. Ratcliffe,et al. Late referral for maintenance dialysis. , 1984, British medical journal.
[245] N. Lawson,et al. Creatinine Assays: Time for Action? , 2002, Annals of clinical biochemistry.
[246] C. McCulloch,et al. Iron status and hemoglobin level in chronic renal insufficiency. , 2002, Journal of the American Society of Nephrology : JASN.
[247] S. Travis,et al. Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.
[248] P. Eskildsen,et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. , 1999, Kidney international.
[249] P. Kalra,et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure , 1998, The Lancet.
[250] T. Lehtimäki,et al. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. , 2003, Clinical chemistry.
[251] Thomas E. Moritz,et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery , 1999 .
[252] D. Neal,et al. The role of the ileal conduit in the development of upper tract dilatation. , 1985, British journal of urology.
[253] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[254] P. Rowe,et al. Early deaths on renal replacement therapy: the need for early nephrological referral. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[255] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[256] A. Rees,et al. Towards a more rapid diagnosis of rapidly progressive glomerulonephritis. , 1990, BMJ.
[257] B. Palmer. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[258] G. Blake,et al. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[259] D. Eadington. Delayed referral for dialysis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[260] S. Shapiro,et al. Fate of 90 children with ileal conduit urinary diversion a decade later: analysis of complications, pyelography, renal function and bacteriology. , 1975, The Journal of urology.
[261] N. Kock,et al. Renal function and upper urinary tract configuration following urinary diversion to a continent ileal reservoir (Kock pouch): a prospective 5 to 11-year followup after reservoir construction. , 1989, The Journal of urology.
[262] B. Palmer. Renal dysfunction complicating the treatment of hypertension. , 2002, The New England journal of medicine.
[263] M. Wiseman,et al. The dietary and nutritional survey of British adults. , 1990 .
[264] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[265] D. Zimmerman,et al. Attitudes of Canadian nephrologists, family physicians and patients with kidney failure toward primary care delivery for chronic dialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[266] I. Khan,et al. Chronic renal failure: factors influencing nephrology referral. , 1994, QJM : monthly journal of the Association of Physicians.
[267] LONDON: HER MAJESTY'S STATIONERY OFFICE , 2022 .
[268] S. Solomon,et al. Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction: The Survival And Ventricular Enlargement (SAVE) Study , 2004, Circulation.
[269] E. Peile,et al. Significance of dipstick haematuria. 1. Correlation with microscopy of the urine. , 1986, British journal of urology.
[270] J. Craig,et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review , 2004, BMJ : British Medical Journal.
[271] C M Bannister,et al. Investigative Techniques and Renal Parenchymal Damage in Children with Spina Bifida , 1994, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[272] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[273] I. Dasgupta,et al. Management of hypertension in patients developing end-stage renal failure. , 1999, QJM : monthly journal of the Association of Physicians.
[274] D. Levy,et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. , 1999, Archives of internal medicine.
[275] I. Shapira,et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.
[276] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[277] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[278] B. Kasiske,et al. Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.
[279] A. Levin,et al. Elevated levels of serum creatinine: recommendations for management and referral. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[280] L. Gøransson,et al. Consequences of late referral of patients with end‐stage renal disease , 2001, Journal of internal medicine.
[281] R. Bilous. End‐stage renal failure and management of diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[282] C. Jurkovitz,et al. Family members of patients treated for ESRD have high rates of undetected kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[283] P. Ravaud,et al. Medication misuse in hospitalized patients with renal impairment. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[284] M. Blaufox,et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.
[285] H. Mamtora,et al. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. , 1990, The Quarterly journal of medicine.
[286] A. Garg,et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. , 2003, Kidney international.
[287] Aziz Sheikh,et al. Prescribing safety features of general practice computer systems: evaluation using simulated test cases , 2004, BMJ : British Medical Journal.
[288] G. Johnson,et al. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[289] J F Potter,et al. Extract from : , 2009 .
[290] E. Ritz,et al. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? , 2004, Kidney international.
[291] K. Lynn,et al. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. , 1998, Clinical nephrology.
[292] W. Goodman. Vascular calcification in chronic renal failure , 2001, The Lancet.
[293] Diederick E. Grobbee,et al. Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.
[294] V. Dharnidharka,et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[295] G. MacGregor,et al. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[296] R. Sesso,et al. Nephrology Dialysis Transplantation Late diagnosis of chronic renal failure and mortality on maintenance dialysis , 2005 .
[297] T. Greene,et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[298] W. Cattell,et al. Proteinuria: Pathophysiology, Significance and Recommendations for Measurement in Clinical Practice , 1993, Annals of clinical biochemistry.
[299] G. Curhan,et al. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. , 2002, Journal of the American Society of Nephrology : JASN.
[300] C. Price,et al. Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR. , 1994, Kidney international. Supplement.
[301] M. Langman,et al. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines , 2002, Gut.
[302] S. Ott,et al. Osteoporosis in chronic kidney disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[303] B. Kasiske,et al. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.
[304] G. Hamilton,et al. Patients with atherosclerotic renovascular disease presenting to a renal unit: an audit of outcome. , 1993, Postgraduate medical journal.
[305] O. Ifudu. Kidney-related malpractice suits: A clinical analysis , 2002 .
[306] W. Keane. Lipids and the kidney. , 1994, Kidney international.
[307] G. Curhan,et al. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. , 2002, Kidney international.
[308] M. Bédard,et al. Renal impairment and medication use among psychogeriatric inpatients. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[309] A. Cass,et al. Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis , 2002, The Medical journal of Australia.
[310] G. Remuzzi,et al. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). , 1998, Journal of the American Society of Nephrology : JASN.
[311] J. Cleland,et al. Unsuspected renal artery stenosis in peripheral vascular disease. , 1990, BMJ.
[312] E. Ejerblad,et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[313] A. Prentice,et al. The National Diet and Nutrition Survey: people aged 65 years and over , 1998 .
[314] David W Dunstan,et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. , 2003, Journal of the American Society of Nephrology : JASN.
[315] G. Spasovski,et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[316] A. Bellucci,et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[317] N. Waugh,et al. Protein restriction for diabetic renal disease. , 2007, The Cochrane database of systematic reviews.
[318] E. Ritz,et al. The renal risks of smoking: an update , 2002, Current opinion in nephrology and hypertension.
[319] P. Glasziou,et al. Monitoring in chronic disease: a rational approach , 2005, BMJ : British Medical Journal.
[320] J. Wolfe,et al. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease , 2002, The British journal of surgery.
[321] J. Dunn,et al. Repeat testing for haematuria and underlying urological pathology. , 1994, British journal of urology.
[322] I. Ala-Houhala,et al. Proteinuria and renal function during and after acute urinary retention. , 1999, The Journal of urology.
[323] N W Shock,et al. Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.
[324] S. Rogers,et al. Adverse effects with long‐term cyclosporin for severe psoriasis , 2002, Clinical and experimental dermatology.
[325] B. Materson,et al. Renal Biopsy in Patients 65 Years of Age or Older An Analysis of the Results of 334 Biopsies , 1990, Journal of the American Geriatrics Society.
[326] A. Logan,et al. Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction. , 2003, The Cochrane database of systematic reviews.
[327] P. Roderick,et al. The need and demand for renal replacement therapy in ethnic minorities in England. , 1996, Journal of epidemiology and community health.
[328] C. Lang,et al. Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.
[329] R. P. Shah,et al. The impact of percutaneous renal biopsies on clinical management. , 1993, Annals of the Academy of Medicine, Singapore.
[330] A. Hoes,et al. Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors , 2003, Drug safety.
[331] M. Mauer,et al. Preventing microalbuminuria in type 2 diabetes. , 2005, The New England journal of medicine.
[332] C D Mistry,et al. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. , 1990, BMJ.
[333] P. Roderick,et al. Late referral for dialysis: improving the management of chronic renal disease. , 2002, QJM : monthly journal of the Association of Physicians.
[334] D. Marcelli,et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[335] J. Halimi,et al. Renal effects of smoking: potential mechanisms and perspectives. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[336] B. Freedman,et al. Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.
[337] P. Pattynama,et al. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? , 2001, Kidney international.
[338] P. Pillans,et al. Evaluation of dosage adjustment in patients with renal impairment , 2003, Internal medicine journal.
[339] B. Pereira,et al. Prospective trials on anemia of chronic disease: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). , 2003, Kidney international. Supplement.
[340] A. Nissenson,et al. The role of renal biopsy in determining therapy and prognosis in renal disease. , 1982, American journal of nephrology.
[341] P. Smith,et al. The long-term results of ileal conduit urinary diversion in children. , 1979, British journal of urology.
[342] M. Schroll,et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[344] T. Bodenheimer,et al. Patient self-management of chronic disease in primary care. , 2002, JAMA.
[345] E. Friedman,et al. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[346] P. Fein,et al. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[347] J. Glowacki,et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. , 1999, JAMA.
[348] L. Bouter,et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. , 2002, Kidney international.
[349] E W Young,et al. Type of vascular access and mortality in U.S. hemodialysis patients. , 2001, Kidney international.
[350] J. Coresh,et al. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1997, Journal of the American Society of Nephrology : JASN.
[351] A. Baert,et al. The angiographic incidence of renal artery stenosis in the arteriosclerotic population. , 1990, European journal of radiology.
[352] S. Geberth,et al. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[353] C. Price,et al. Prognostic significance of serum cystatin c concentrations in renal transplant recipients: 5-year follow-up. , 2002, Transplantation proceedings.
[354] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[355] K. Kreder,et al. Spine update. Urological management in patients with spinal cord injuries. , 1996, Spine.
[356] E. Briganti,et al. Association between albuminuria and proteinuria in the general population: the AusDiab Study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[357] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[358] C. Price,et al. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance , 2000, Annals of clinical biochemistry.
[359] M. Salvadori,et al. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[360] K. Harris. Cardiovascular risk factors in progressive renal disease. , 2002, Clinical medicine.
[361] C. Jurkovitz,et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.
[362] W. Pitts,et al. A 20-year experience with ileal conduits: the fate of the kidneys. , 1979, The Journal of urology.
[363] C. Schmid,et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. , 2001, Kidney international.
[364] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[365] J. Kaneti,et al. Fate of nonneurogenic neurogenic bladder--end-stage renal failure. , 1988, European urology.
[366] A. Veraksitš,et al. Regular low-intensity aquatic exercise improves cardio-respiratory functional capacity and reduces proteinuria in chronic renal failure patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[367] J. Beizer,et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. , 2005, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
[368] U. Bergerheim,et al. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas , 1995, Histopathology.
[369] Raymond Vanholder,et al. The burden of kidney disease: improving global outcomes. , 2004, Kidney international.
[370] H. Parving,et al. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[371] C. Tribe,et al. Renal biopsy in the elderly: clinicopathological correlations in 143 patients. , 1984, Clinical nephrology.
[372] G. R. Schwarz,et al. Ileal conduit urinary diversion in children: computer analysis of followup from 2 to 16 years. , 1975, The Journal of urology.
[373] Ü. Pechter,et al. Beneficial effects of water-based exercise in patients with chronic kidney disease , 2003, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.
[374] F. Kronenberg,et al. Cigarette smoking and vascular pathology in renal biopsies. , 2002, Kidney international.
[375] P. Jungers. Late referral: loss of chance for the patient, loss of money for society. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[376] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[377] L. Dworkin,et al. Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[378] Jeffrey Rimmer,et al. Atherosclerotic Renovascular Disease and Progressive Renal Failure , 1993, Annals of Internal Medicine.
[379] Nancy Fink,et al. The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.
[380] R. Hiatt,et al. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[381] K. Iseki,et al. Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.
[382] I. D. de Boer,et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. , 2002, Journal of the American Society of Nephrology : JASN.
[383] A. Meyrier,et al. Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[384] Giuseppe Remuzzi,et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.
[385] Charles Normand,et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study , 2000, The Lancet.
[386] C. Wanner,et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. , 1998, Kidney international.
[387] R. Sesso,et al. Nephrology Dialysis Transplantation Time of Diagnosis of Chronic Renal Failure and Assessment of Quality of Life in Haemodialysis Patients , 2022 .
[388] J. Olin,et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. , 1990, The American journal of medicine.
[389] J. Feinglass,et al. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs' National Surgical Quality Improvement Program. , 2003, Journal of the American Society of Nephrology : JASN.
[390] A. Ludbrook,et al. Early referral and planned initiation of dialysis: what impact on quality of life? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[391] C. Wilcox,et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. , 2003, Kidney international.
[392] O. Djurdjev,et al. Screening for renal disease using serum creatinine: who are we missing? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[393] J. Breyer,et al. Atherosclerotic ischemic renal disease. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[394] M. Taal,et al. Total hip bone mass predicts survival in chronic hemodialysis patients. , 2003, Kidney international.
[395] S. Yusuf,et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.
[396] N. Day,et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. , 2004, International journal of epidemiology.
[397] D. Molony,et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. , 2003, Kidney international.
[398] I. Kallikazaros,et al. Microalbuminuria Is Closely Related to Impaired Arterial Elasticity in Untreated Patients with Essential Hypertension , 2003, Nephron Clinical Practice.
[399] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[400] E A Balas,et al. Improving preventive care by prompting physicians. , 2000, Archives of internal medicine.
[401] E. Peile,et al. Significance of dipstick haematuria. 2. Correlation with pathology. , 1986, British journal of urology.
[402] L. Stevens,et al. The profile of cardiac patients with renal artery stenosis. , 2004, Journal of the American College of Cardiology.
[403] A. Zanchetti,et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.
[404] P. Jungers,et al. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[405] E. Ritz,et al. Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[406] K. Iseki,et al. Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.
[407] B. Ballermann,et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. , 2001, Circulation.
[408] K. Kreder,et al. Urological Management in Patients With Spinal Cord Injuries , 1996 .
[409] W. McClellan,et al. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. , 2003, Kidney international.
[410] D. Mark,et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. , 2001, Kidney international.
[411] T. Larson,et al. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. , 1999, Journal of the American Society of Nephrology : JASN.
[412] P. Malmström. Time to abandon testing for microscopic haematuria in adults? , 2003, BMJ : British Medical Journal.
[413] J. Willner,et al. Renal function up to 16 years after conduit (refluxing or anti-reflux anastomosis) or continent urinary diversion. 2. Renal scarring and location of bacteriuria. , 1995, British journal of urology.
[414] M. Silveri,et al. Long-Term Urological Follow-Up of Occult Spinal Dysraphism in Children , 1996, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[415] B. Brenner,et al. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. , 2004, Kidney international.
[416] I. Shapira,et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.
[417] M. Mauer,et al. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. , 2003, Diabetes.
[418] G. Bakris,et al. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.
[419] D. Newman. Cystatin C: What More Do We Need to Know? , 2003, Nephron Clinical Practice.
[420] C. Price,et al. Use of urine albumin measurement as a replacement for total protein. , 1995, Clinical nephrology.
[421] H. Parving,et al. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. , 2003, Kidney international.
[422] S. Adler,et al. Clinical utility of kidney biopsies in the diagnosis and management of renal disease. , 1989, American journal of nephrology.
[423] M. Shlipak,et al. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. , 2003, Journal of the American Society of Nephrology : JASN.
[424] W. Mcdougal,et al. Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. , 1992, The Journal of urology.
[425] R. Huisman. The deadly risk of late referral. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[426] P. Lapuerta,et al. Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and re , 2004, Diabetes care.
[427] P. Stevens,et al. Unreferred chronic kidney disease: a longitudinal study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[428] R. Errico,et al. Survival of patients with renovascular disease and ACE inhibition. , 1999, Clinical nephrology.
[429] P. Zucchelli,et al. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[430] P. Stevens,et al. Stability of parathyroid hormone ex vivo in haemodialysis patients , 2003, Annals of clinical biochemistry.
[431] R. Grainger,et al. Comparison of reagent strip (dipstick) and microscopic haematuria in urological out-patients. , 1993, British journal of urology.
[432] G. Breithardt,et al. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. , 2003, Kidney international.
[433] R. Califf,et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. , 2001, Kidney international.
[434] A. Levin. The advantage of a uniform terminology and staging system for chronic kidney disease (CKD). , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[435] T. Hutchinson,et al. A prospective study on the impact of the renal biopsy in clinical management. , 1986, Clinical nephrology.
[436] R. Rees,et al. A long-term follow-up of the colonic conduit operation in children. , 1979, British journal of urology.
[437] B. Kasiske. Relationship between vascular disease and age-associated changes in the human kidney. , 1987, Kidney international.
[438] C. Schmid,et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.
[439] D. de Zeeuw,et al. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? , 2003, Nephrology, Dialysis and Transplantation.
[440] G. Remuzzi,et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.
[441] C. Palmer,et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. , 2004, Archives of internal medicine.
[442] S Woolhandler,et al. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. , 1989, JAMA.
[443] Christopher H Schmid,et al. Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.
[444] S. Harper,et al. Glomerular disease as a cause of isolated microscopic haematuria. , 1994, The Quarterly journal of medicine.
[445] P. Houillier,et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. , 2005, Journal of the American Society of Nephrology : JASN.
[446] L. Ruilope,et al. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease , 2001, Journal of hypertension.
[447] R. Selgas,et al. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain]. , 2002, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[448] Andrej Sali. Target practice , 2001, Nature Structural Biology.
[449] S. Romundstad,et al. Clinical relevance of microalbuminuria screening in self-reported non-diabetic/non-hypertensive persons identified in a large health screening--the Nord-Trøndelag Health Study (HUNT), Norway. , 2003, Clinical nephrology.
[450] T. Risler,et al. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[451] L. Ibels,et al. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. , 2004, Kidney international.
[452] M. Tinetti,et al. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. , 2004, The New England journal of medicine.
[453] T. Larson,et al. The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial , 1999 .
[454] J. Floege,et al. Vascular calcification in patients with end-stage renal disease. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[455] S. Yusuf,et al. Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. , 2003, Journal of the American Society of Nephrology : JASN.
[456] Thomas Bodenheimer,et al. Improving primary care for patients with chronic illness: the chronic care model, Part 2. , 2002, JAMA.
[457] Ping Wang,et al. The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.
[458] D. Schwartz,et al. Intravenous iron for the treatment of predialysis anemia. , 1999, Kidney international. Supplement.
[459] N. Shock,et al. Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.
[460] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[461] F. Port,et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[462] J Pascual,et al. Epidemiology of acute renal failure: A prospective, multicenter, community-based study , 1996 .
[463] D. Newman,et al. Cystatin C improves the detection of mild renal dysfunction in older patients , 2003, Annals of clinical biochemistry.
[464] W. März,et al. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators. , 1999, Kidney international. Supplement.
[465] B. Myers,et al. Course of acute renal failure studied by a model of creatinine kinetics. , 1985, Kidney international.
[466] H. Oksa,et al. Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. , 1993, Journal of clinical pathology.
[467] R. Fischer,et al. Stopping smoking slows accelerated progression of renal failure in primary renal disease. , 2002, Journal of nephrology.
[468] M. Silveri,et al. Occult spinal dysraphism: neurogenic voiding dysfunction and long-term urologic follow-up , 1997, Pediatric Surgery International.
[469] J. Fink,et al. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[470] A. Kausz,et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. , 1999, Journal of the American Society of Nephrology : JASN.
[471] G. Leoncini,et al. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. , 2002, Journal of hypertension.
[472] R. Bellomo,et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.
[473] E. Lamb,et al. Estimation of Glomerular Filtration Rate in Older Patients with Chronic Renal Insufficiency: Is the Modification of Diet in Renal Disease Formula an Improvement? , 2003, Journal of the American Geriatrics Society.
[474] F. Locatelli,et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[475] L. Irwig,et al. Feasibility study of the early detection and treatment of renal disease by mass screening , 2002, Internal medicine journal.
[476] A. Zuccalà,et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. , 1992, Kidney international.
[477] T. Greene,et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. , 1995, Annals of internal medicine.
[478] E. Bonucci,et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[479] B. Horne,et al. Impact of renal failure on the risk of myocardial infarction and death. , 2002, Kidney international.
[480] R. Lepage,et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. , 1996, The Journal of clinical endocrinology and metabolism.
[481] F. Locatelli,et al. Corticosteroids in IgA nephropathy: a randomised controlled trial , 1999, The Lancet.
[482] 汪关煜. Renal osteodystrophy , 2002 .
[483] M. Rambausek,et al. Frequency of mesangial IgA deposits in a non-selected autopsy series. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[484] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[485] Tom Greene,et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[486] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[487] J. Squifflet,et al. Lesions in donor kidneys: nature, incidence, and influence on graft function , 1998, Transplant international : official journal of the European Society for Organ Transplantation.
[488] D. Adu,et al. Knowledge of renal histology alters patient management in over 40% of cases. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[489] R. Albright,et al. Proteinuria in congestive heart failure. , 1983, American journal of nephrology.
[490] D. Hémon,et al. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. , 2000, Kidney international.
[491] H. W. Jones,et al. An analysis of discharge drug prescribing amongst elderly patients with renal impairment. , 1998, Postgraduate medical journal.
[492] C. Tomson,et al. Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence , 2002, BJU international.
[493] A. Novick,et al. Natural history of atherosclerotic and fibrous renal artery disease: clinical implications. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[494] P. Bacon,et al. Renal involvement in systemic amyloidosis. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.
[495] P. Shah,et al. Vesico-ureteric reflux in adult patients with spinal injury. , 1997, British journal of urology.
[496] P. Whelton,et al. A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study , 1993 .
[497] S. Mansoor,et al. 'Flash pulmonary oedema'--a diagnosis for both the cardiologist and the nephrologist? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[498] P. Pattynama,et al. Predictors for Clinical Success at One Year following Renal Artery Stent Placement , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[499] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[500] J. Fuller,et al. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes. , 1996, Diabetes care.
[501] Ewout Steyerberg,et al. A Clinical Prediction Rule for Renal Artery Stenosis , 1998, Annals of Internal Medicine.
[502] H. Clark,et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. , 2004, Archives of internal medicine.
[503] P. Poulsen,et al. Microalbuminuria and Potential Confounders: A review and some observations on variability of urinary albumin excretion , 1995, Diabetes Care.
[504] R. Brown,et al. Renal Insufficiency and Secondary Hyperparathyroidism in Elderly Patients , 1991, Annals of clinical biochemistry.
[505] F. Locatelli,et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.
[506] D. E. Strandness,et al. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. , 1994, Journal of vascular surgery.
[507] S. Paydaş. Report on 59 Patients with Renal Amyloidosis , 1999, International Urology and Nephrology.
[508] G. Beck,et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.
[509] D Hernández,et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.
[510] D. Grobbee,et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity , 2001, Journal of internal medicine.
[511] K. Eckardt,et al. The CREATE trial--building the evidence. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[512] E. Lonn,et al. Cardiovascular risk in patients with mild renal insufficiency. , 2003, Kidney international. Supplement.
[513] G. Bakris,et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. , 2005, Kidney international.
[514] J. Avorn,et al. Late referral and modality choice in end-stage renal disease. , 2001, Kidney international.
[515] K. Hu,et al. Calculation of the Estimated Creatinine Clearance in Avoiding Drug Dosing Errors in the Older Patient , 2001, The American journal of the medical sciences.
[516] M. Emoto,et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. , 1999, Kidney international.
[517] D. Fliser,et al. Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[518] D. Holmes,et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. , 2002, Mayo Clinic proceedings.
[519] Thomas Bodenheimer,et al. Improving primary care for patients with chronic illness. , 2002, JAMA.
[520] D. Fliser,et al. Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.
[521] W. März,et al. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis , 1999 .
[522] K. Iseki,et al. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. , 1997, Kidney international.
[523] Mansour Razminia,et al. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[524] P. Kalra,et al. Proteinuria in atherosclerotic renovascular disease. , 1999, QJM : monthly journal of the Association of Physicians.
[525] C. Price,et al. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. , 1999, Clinical chemistry.